Home
OrbiMed Capital GP VI, 10% Owner: NeuroPace NPCE Sell · Filed 24/04/23
Trade details
- Type
- Insider sale
- Amount
- $345,756.45
- Shares · price
- 24,609 sh · $14.05 a share
- Held after
- 3,459,113 sh
- Stock
- NeuroPace NPCE
- Trade date
- 24/04/22
- Filed
- 24/04/23
- Days to filing
- 1 days
Sold 0.7% of holdings
- Share of holding sold
- 0.7%
NeuroPace trades, last 26 weeks
What else happened in NeuroPace around then
Filed or reported within 30 days of the trade day · 24/03/23~24/05/22OrbiMed Capital GP VI's recent trades
- OrbiMed Capital GP VI
BuyPrelude Therapeutics
BuyPrelude Therapeutics
PRLD
$7.5M
1,689,189 sh
$7.5M
Filed 04/23
Traded 04/21
- OrbiMed Capital GP VI
BuyPrelude Therapeutics
BuyPrelude Therapeutics
PRLD
$5M
1,126,126 sh
$5M
Filed 04/23
Traded 04/21
- OrbiMed Capital GP VI
SellAdicet Bio
SellAdicet Bio
ACET
$263.5K
40,416 sh
$263.5K
Filed 04/09
Traded 04/08
- OrbiMed Capital GP VI
SellAdicet Bio
SellAdicet Bio
ACET
$204.6K
32,523 sh
$204.6K
Filed 04/09
Traded 04/08
- OrbiMed Capital GP VI
SellAdicet Bio
SellAdicet Bio
ACET
$191.5K
29,319 sh
$191.5K
Filed 04/09
Traded 04/07
